Efficacy of Oral Ribavirin in Lung Transplant Patients With Respiratory Syncytial Virus Lower Respiratory Tract Infection

BACKGROUND: Respiratory syncytial virus (RSV) can cause severe lower respiratory tract infection (LRI) and is a risk factor for the development of bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx). Currently, the most widely used therapy for RSV is inhaled ribavirin. However,...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Pelaez, Andres, Lyon, G. Marshall, Force, Seth D., Ramirez, Allan M., Neujahr, David C., Foster, Marianne, Naik, Priyumvada M., Gal, Anthony A., Mitchell, Patrick O., Lawrence, E. Clinton
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2009
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3395057/
https://ncbi.nlm.nih.gov/pubmed/19134533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.healun.2008.10.008
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk